Form D Friday: Dallas’ growing biotech hub part of $75M funding round


A Dallas biotech investment firm raised more than $2.1 million as part of a round of funding it participated in for a cancer drug maker in Belgium, a filing shows.

Previous Avondale redevelopment filling up as retail tenants sign on
Next Stanford to host industry-funded blockchain research center